334 related articles for article (PubMed ID: 22685567)
1. TRAM is involved in IL-18 signaling and functions as a sorting adaptor for MyD88.
Ohnishi H; Tochio H; Kato Z; Kawamoto N; Kimura T; Kubota K; Yamamoto T; Funasaka T; Nakano H; Wong RW; Shirakawa M; Kondo N
PLoS One; 2012; 7(6):e38423. PubMed ID: 22685567
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling.
Ohnishi H; Tochio H; Kato Z; Orii KE; Li A; Kimura T; Hiroaki H; Kondo N; Shirakawa M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10260-5. PubMed ID: 19506249
[TBL] [Abstract][Full Text] [Related]
3. TRAM is required for TLR2 endosomal signaling to type I IFN induction.
Stack J; Doyle SL; Connolly DJ; Reinert LS; O'Keeffe KM; McLoughlin RM; Paludan SR; Bowie AG
J Immunol; 2014 Dec; 193(12):6090-102. PubMed ID: 25385819
[TBL] [Abstract][Full Text] [Related]
4. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway.
Yamamoto M; Sato S; Hemmi H; Uematsu S; Hoshino K; Kaisho T; Takeuchi O; Takeda K; Akira S
Nat Immunol; 2003 Nov; 4(11):1144-50. PubMed ID: 14556004
[TBL] [Abstract][Full Text] [Related]
5. A TIR domain variant of MyD88 adapter-like (Mal)/TIRAP results in loss of MyD88 binding and reduced TLR2/TLR4 signaling.
Nagpal K; Plantinga TS; Wong J; Monks BG; Gay NJ; Netea MG; Fitzgerald KA; Golenbock DT
J Biol Chem; 2009 Sep; 284(38):25742-8. PubMed ID: 19509286
[TBL] [Abstract][Full Text] [Related]
6. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
7. Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.
Dunne A; Ejdeback M; Ludidi PL; O'Neill LA; Gay NJ
J Biol Chem; 2003 Oct; 278(42):41443-51. PubMed ID: 12888566
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Regulatory Acidic Motif as the Determinant of Membrane Localization of TICAM-2.
Funami K; Matsumoto M; Enokizono Y; Ishii N; Tatematsu M; Oshiumi H; Inagaki F; Seya T
J Immunol; 2015 Nov; 195(9):4456-65. PubMed ID: 26408662
[TBL] [Abstract][Full Text] [Related]
9. Modulation of Toll-interleukin 1 receptor mediated signaling.
Li X; Qin J
J Mol Med (Berl); 2005 Apr; 83(4):258-66. PubMed ID: 15662540
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
[TBL] [Abstract][Full Text] [Related]
11. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
12. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
Horng T; Barton GM; Flavell RA; Medzhitov R
Nature; 2002 Nov; 420(6913):329-33. PubMed ID: 12447442
[TBL] [Abstract][Full Text] [Related]
13. Identification of binding sites for myeloid differentiation primary response gene 88 (MyD88) and Toll-like receptor 4 in MyD88 adapter-like (Mal).
Bovijn C; Desmet AS; Uyttendaele I; Van Acker T; Tavernier J; Peelman F
J Biol Chem; 2013 Apr; 288(17):12054-66. PubMed ID: 23460645
[TBL] [Abstract][Full Text] [Related]
14. Crystal structures of the Toll/Interleukin-1 receptor (TIR) domains from the Brucella protein TcpB and host adaptor TIRAP reveal mechanisms of molecular mimicry.
Snyder GA; Deredge D; Waldhuber A; Fresquez T; Wilkins DZ; Smith PT; Durr S; Cirl C; Jiang J; Jennings W; Luchetti T; Snyder N; Sundberg EJ; Wintrode P; Miethke T; Xiao TS
J Biol Chem; 2014 Jan; 289(2):669-79. PubMed ID: 24275656
[TBL] [Abstract][Full Text] [Related]
15. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
[TBL] [Abstract][Full Text] [Related]
16. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
[TBL] [Abstract][Full Text] [Related]
17. TIR domain-containing adaptors define the specificity of TLR signaling.
Yamamoto M; Takeda K; Akira S
Mol Immunol; 2004 Feb; 40(12):861-8. PubMed ID: 14698224
[TBL] [Abstract][Full Text] [Related]
18. Poxviral protein A46 antagonizes Toll-like receptor 4 signaling by targeting BB loop motifs in Toll-IL-1 receptor adaptor proteins to disrupt receptor:adaptor interactions.
Stack J; Bowie AG
J Biol Chem; 2012 Jun; 287(27):22672-82. PubMed ID: 22593572
[TBL] [Abstract][Full Text] [Related]
19. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins.
Watters TM; Kenny EF; O'Neill LA
Immunol Cell Biol; 2007; 85(6):411-9. PubMed ID: 17667936
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of four TIR domain-containing adaptors, MyD88, TRIF, MAL, and SARM in mandarin fish Siniperca chuatsi.
Wang KL; Chen SN; Li L; Huo HJ; Nie P
Dev Comp Immunol; 2021 Sep; 122():104110. PubMed ID: 33933533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
